Mandate

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), an innovative and integrated pharmaceutical company focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment, listed on Nasdaq Stockholm, in connection with a directed share issue whereby the company raised proceeds of SEK 210 million before issue costs.

The share issue was directed to a number of selected Swedish and international institutional investors on the basis of an accelerated bookbuilding process.

Vinge’s team consisted of Dain Hård Nevonen, Amanda Knutsson and Lorin Arabi.

Related

Vinge advises Zellis Group, a portfolio company of Apax Partners, in connection with the acquisition of Benify

Vinge has, together with Kirkland & Ellis, advised Zellis Group, a portfolio companya of funds advised by Apax Partners LLP (“Apax”), in connection with the acquisition of Benify, a provider of employee benefits administration software, from Vitruvian Partners and the other shareholders.
September 09, 2024

Vinge advises Blue Wolf Capital Partners in connection with the acquisition of seven manufacturing and development facilities from Recipharm

Vinge has, together with Kirkland & Ellis, advised Blue Wolf Capital Partners LLC (“Blue Wolf”), a middle market private equity firm specializing in the healthcare and industrial sectors, in connection with the acquisition of seven manufacturing and development facilities in Sweden, France, and Spain, from Recipharm Group, a contract development and manufacturing organization (“CDMO”) headquartered in Stockholm.
September 03, 2024

Vinge advises on the sale of Märta Måås-Fjetterström’s business

Vinge has advised the Swedrup family in connection with the sale of Märta Måås-Fjetterström, Verkstaden för svenska mattor och vävnader Aktiebolag. The company manufactures rugs and tapestries in Båstad based on designs by both Märta Måås-Fjetterström herself and her successors, such as Barbro Nilsson, Marianne Richter, Ann-Mari Forsberg and others. The buyer is the Hult family.
September 03, 2024